Mandelia Ashish

CIK 00017828051 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001782805

Recent Transactions

50 trades

Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−666→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−773→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−310→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−44→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−555→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−2,870→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,312→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,687→ 0 total
Disposition from Tender
Mersana Therapeutics, Inc.$MRSN
Common Stock
2026-01-06−2,300→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−500→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−212→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Units
2026-01-06−192→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,842→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,157→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,183→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−722→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−788→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−359→ 0 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-16$0.58/sh−3,554→ 57,519 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-15+4,519→ 56,907 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-15+16,667→ 16,667 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-15−4,166→ 12,501 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (Right to Buy)
2025-01-15+75,000→ 75,000 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-15−4,519→ 0 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-15$0.63/sh−1,791→ 52,388 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-15+4,166→ 61,073 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-14$0.66/sh−1,007→ 49,396 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-14−4,783→ 4,783 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-14+4,783→ 54,179 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2025-01-13−2,646→ 5,292 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2025-01-13+2,646→ 50,403 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-03$1.96/sh−3,361→ 47,757 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-02$2.00/sh−4,855→ 51,118 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-10-01+30,000→ 55,973 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-10-01−30,000→ 0 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-16$2.71/sh−5,025→ 23,328 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-15−833→ 0 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-15−4,519→ 4,519 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-15+16,667→ 16,667 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (Right to Buy)
2024-01-15+75,000→ 75,000 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-15+4,519→ 27,520 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-15+833→ 28,353 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-14−4,783→ 9,566 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-14+4,783→ 23,001 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2024-01-13+2,645→ 18,218 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted Stock Unit
2024-01-13−2,645→ 7,938 total
Award
Mersana Therapeutics, Inc.$MRSN
Restricted stock unit
2023-09-05+30,000→ 30,000 total
Sale
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-01-17$5.74/sh−3,575→ 13,619 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Restricted stock unit
2023-01-15−833→ 833 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-01-15+833→ 17,194 total

Companies

Mersana Therapeutics, Inc.
VP, Chief Accounting Officer
$MRSN

Recent Filings

Address

C/O MERSANA THERAPEUTICS, INC. 840 MEMORIAL DRIVE

CAMBRIDGE, MA, 02139

View on SEC.gov